project id: TCGA-CESC; case submitter id: TCGA-JW-A5VJ; no matched normal low pass wgs: false; no matched normal targeted sequencing: false; no matched normal wgs: false; no matched normal wxs: false; selected normal low pass wgs: false; selected normal targeted sequencing: false; selected normal wgs: false; selected normal wxs: false; source center: 23; state: released; a260 a280 ratio: 1.92; normal tumor genotype snp match: Yes; ribosomal rna 28s 16s ratio: 1.45; rna integrity number: 8.8; age at index: 56; days to birth: -20714; ethnicity: hispanic or latino; gender: female; race: american indian or alaska native; vital status: Alive; year of birth: 1956; age at diagnosis: 20714; ajcc pathologic m: MX; ajcc pathologic n: NX; ajcc pathologic t: T2b; classification of tumor: not reported; days to diagnosis: 0; days to last follow up: 652.0; figo stage: Stage IIB; icd 10 code: C53.9; last known disease status: not reported; morphology: 8070/3; primary diagnosis: Squamous cell carcinoma, NOS; prior malignancy: no; prior treatment: No; progression or recurrence: not reported; site of resection or biopsy: Cervix uteri; synchronous malignancy: No; tissue or organ of origin: Cervix uteri; tumor grade: Not Reported; year of diagnosis: 2012; treatment or therapy: yes; alcohol history: Not Reported; is ffpe: false; composition: Not Reported; days to collection: 301; initial weight: 60.0; oct embedded: false; preservation method: Unknown; sample id: 0fc6e478-1fa9-430c-96ea-b14fb2101181; sample submitter id: TCGA-JW-A5VJ-01A; portion id: 42ccd200-b700-4f4f-87e6-f521ef254ee5; portion submitter id: TCGA-JW-A5VJ-01A-11; slide id: 361f37c4-3d55-4484-b4f6-caab18d2a7d9; slide submitter id: TCGA-JW-A5VJ-01A-01-TS1; percent lymphocyte infiltration: 40.0; percent monocyte infiltration: 20.0; percent necrosis: 0.0; percent neutrophil infiltration: 20.0; percent normal cells: 0.0; percent stromal cells: 10.0; percent tumor cells: 90.0; percent tumor nuclei: 90.0; section location: TOP;